Literature DB >> 7762495

Stress-induced left ventricular dysfunction in silent and symptomatic myocardial ischemia during dobutamine stress test.

A Elhendy1, M L Geleijnse, J R Roelandt, J H Cornel, R T van Domburg, P M Fioretti.   

Abstract

The extent and severity of dobutamine-induced left ventricular (LV) dysfunction with and without angina were evaluated in 105 consecutive patients with significant coronary artery disease and a positive dobutamine stress echocardiographic test, defined as new or worsening wall motion abnormalities during high-dose dobutamine stress (up to 40 micrograms/kg/min). Wall motion score (WMS) was derived using a 16-segment, 4-grade scoring method. The difference between stress and rest WMS (delta WMS) was derived as a global measure of stress-induced LV dysfunction. Typical angina occurred in 61 patients (58%) during the test. There was no significant difference between patients with or without angina with respect to age, gender, prevalence of previous myocardial infarction, multivessel disease, or number of diseased coronary arteries. Patients with angina had a higher prevalence of a history of angina before the test. Rest, stress, and delta WMS, number and distribution of ischemic segments, and number of segments with an increase in regional WMS of > or = 2 were not significantly different in patients with or without angina. ST-segment depression was more frequent in patients with angina (56% vs 29%, p < 0.05). Patients with (vs those without) ST-segment depression had a significantly higher number of ischemic segments with normal baseline contraction, an equal total number of ischemic segments, and a similar delta WMS. It is concluded that in patients with anatomically and functionally significant coronary artery disease, the amount of stress-induced LV dysfunction evaluated by dobutamine stress echocardiography is similar in patients with or without angina.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7762495     DOI: 10.1016/s0002-9149(99)80740-1

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  2 in total

1.  Patients' profiles in end stage coronary artery disease. Indications for treatment with transmyocardial laser revascularisation.

Authors:  R C Funck; L Rybinski; H König; K Welzel; A Holland; K Ketteler; F Farokhzad; H Höffken; C Bethge; R Moosdorf; B Maisch
Journal:  Herz       Date:  1997-08       Impact factor: 1.443

2.  Altered myocardial perfusion during dobutamine stress testing in silent versus symptomatic myocardial ischaemia assessed by quantitative MIBI SPET imaging.

Authors:  A Elhendy; M L Geleijnse; J R Roelandt; J H Cornel; R T van Domburg; A E Reijs; P R Nierop; P M Fioretti
Journal:  Eur J Nucl Med       Date:  1996-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.